Try our beta test site
10 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) | Enzastaurin
Show Display Options
Rank Status Study
1 Completed A Study of Enzastaurin in Patients With Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention: Drug: enzastaurin
2 Completed Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma
Condition: Mantle-Cell Lymphoma
Intervention: Drug: enzastaurin
3 Active, not recruiting A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
Conditions: Solid Tumor;   Lymphoma, Malignant
Intervention: Drug: Enzastaurin
4 Completed A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: Enzastaurin
5 Completed PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
6 Completed A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
Conditions: Solid Tumor;   Lymphoma, Malignant
Interventions: Drug: warfarin;   Drug: enzastaurin
7 Completed An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only
Condition: Lymphoma
Interventions: Drug: enzastaurin;   Drug: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: vincristine;   Drug: prednisone
8 Active, not recruiting A Study for Patients With Non-Hodgkin's Lymphomas
Conditions: T-Cell Lymphoma;   B-Cell Lymphoma
Intervention: Drug: enzastaurin
9 Completed A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: LY317615
10 Completed Chemotherapy for Patients With Lymphoma
Condition: Lymphoma, Large Cell, Diffuse
Interventions: Drug: enzastaurin;   Drug: gemcitabine;   Drug: rituximab;   Drug: oxaliplatin

Study has passed its completion date and status has not been verified in more than two years.